Ontology highlight
ABSTRACT: Purpose of review
Although type 2 diabetes (T2D) is one of the most important risk factors that leads to the development of de novo heart failure, there are limited data, particularly from a practical/qualitative standpoint, about predictors of heart failure in this population.Recent findings
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been shown to prevent the development of heart failure and the composite of heart failure and cardiovascular death in patients with T2D without known heart failure who have either established atherosclerotic vascular disease or multiple risk factors. The concept of primary prevention of heart failure has led many clinicians to inquire if there are specific risk/enrichment factors that may predict an increased risk of heart failure.Summary
In this review, we identify some general and diabetes-specific risk factors that are associated with an increased risk of developing heart failure in people with T2D.
SUBMITTER: Verma S
PROVIDER: S-EPMC6727884 | biostudies-literature | 2019 Sep
REPOSITORIES: biostudies-literature
Verma Subodh S Sharma Abhinav A Kanumilli Naresh N Butler Javed J
Current opinion in cardiology 20190901 5
<h4>Purpose of review</h4>Although type 2 diabetes (T2D) is one of the most important risk factors that leads to the development of de novo heart failure, there are limited data, particularly from a practical/qualitative standpoint, about predictors of heart failure in this population.<h4>Recent findings</h4>Sodium-glucose cotransporter-2 (SGLT-2) inhibitors have been shown to prevent the development of heart failure and the composite of heart failure and cardiovascular death in patients with T2 ...[more]